Clinical Trial Update: Ritlecitinib for Cicatricial Alopecia [Phase 2]

View source ↗

Summary

Phase 2 trial of ritlecitinib for cicatricial alopecia has completed, with results from the study released.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cicatricial Alopecia

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Emma Guttman | Conditions: Cicatricial Alopecia | Phase 2 | Status: COMPLETED